2nd Quarter - Report

NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)

Firm
Client
Income
—
Expenses
$50,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations.

LobbyistCovered position, as disclosed
MICHAEL JOSEPH BEARD —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Health Issues HCR

Rare Disease Initiatives. Newborn Screening. Genetic Testing Access. Medical Nutrition Equity Act. Medical Foods and Formulas Act. Orphan Drug Act.

LobbyistCovered position, as disclosed
MICHAEL JOSEPH BEARD —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Medicare / Medicaid issues impacting patients with rare diseases.

LobbyistCovered position, as disclosed
MICHAEL JOSEPH BEARD —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Prescription Drug User Fee Act (PDUFA) Reauthorization. User Fee Agreements.

LobbyistCovered position, as disclosed
MICHAEL JOSEPH BEARD —

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.